Kiniksa (KNSA) CMO granted options, RSUs and PSUs in equity awards
Rhea-AI Filing Summary
Kiniksa Pharmaceuticals International, plc reported multiple equity awards and related exercises for its Chief Medical Officer, John F. Paolini, on April 1, 2026. He received a share option for 26,750 Class A Ordinary Shares at an exercise price of $48.13 per share, expiring on March 31, 2036, that vests over time starting April 1, 2026.
He was also granted 6,700 Restricted Share Units and 13,400 Performance Share Units, each linked to Class A Ordinary Shares and subject to four-year time-based or performance-based vesting, with PSUs eligible to convert into up to 200% of one share each by January 30, 2029. In addition, Paolini exercised previously granted RSUs for 5,831 Class A Ordinary Shares, with 2,821 shares withheld at $48.13 per share to cover tax obligations.
Following these transactions, Paolini directly holds 64,334 Class A Ordinary Shares, reflecting routine compensation-related equity activity rather than open-market buying or selling.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option | 26,750 | $0.00 | -- |
| Grant/Award | Restricted Share Unit | 6,700 | $0.00 | -- |
| Grant/Award | Performance Share Unit | 13,400 | $0.00 | -- |
| Exercise | Restricted Share Unit | 1,624 | $0.00 | -- |
| Exercise | Restricted Share Unit | 1,750 | $0.00 | -- |
| Exercise | Restricted Share Unit | 2,457 | $0.00 | -- |
| Exercise | Class A Ordinary Share | 5,831 | $0.00 | -- |
| Tax Withholding | Class A Ordinary Share | 2,821 | $48.13 | $136K |
Footnotes (1)
- Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026. The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter. Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.